These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 30122910)
1. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis. Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910 [TBL] [Abstract][Full Text] [Related]
2. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women. Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743 [TBL] [Abstract][Full Text] [Related]
3. Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration. Gurban CV; Balaş MO; Vlad MM; Caraba AE; Jianu AM; Bernad ES; Borza C; Bănicioiu-Covei S; Motoc AGM Rom J Morphol Embryol; 2019; 60(4):1127-1135. PubMed ID: 32239087 [TBL] [Abstract][Full Text] [Related]
4. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF; Geyikli I; Yazgan P; Celik A Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [TBL] [Abstract][Full Text] [Related]
5. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis. Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507 [TBL] [Abstract][Full Text] [Related]
6. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899 [TBL] [Abstract][Full Text] [Related]
7. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Shaarawy M; Abassi AF; Hassan H; Salem ME Fertil Steril; 2003 Apr; 79(4):919-24. PubMed ID: 12749431 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women. Hu W; He J; Fu W; Wang C; Yue H; Gu J; Zhang H; Zhang Z J Clin Densitom; 2019; 22(2):179-184. PubMed ID: 30228048 [TBL] [Abstract][Full Text] [Related]
9. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290 [TBL] [Abstract][Full Text] [Related]
10. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease. Furman K; Gut P; Sowińska A; Ruchała M; Fichna M Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892 [TBL] [Abstract][Full Text] [Related]
11. Bone turnover in passive smoking female rat: relationships to change in bone mineral density. Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694 [TBL] [Abstract][Full Text] [Related]
12. Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis. Michalska D; Luchavova M; Zikan V; Raska I; Kubena AA; Stepan JJ Osteoporos Int; 2012 Dec; 23(12):2885-91. PubMed ID: 22426952 [TBL] [Abstract][Full Text] [Related]
13. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients. Cao Y; Liu X; Xu H Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989 [TBL] [Abstract][Full Text] [Related]
14. Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females. Lateef M; Baig M; Azhar A Osteoporos Int; 2010 May; 21(5):751-5. PubMed ID: 19597912 [TBL] [Abstract][Full Text] [Related]
15. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563 [TBL] [Abstract][Full Text] [Related]
16. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009 [TBL] [Abstract][Full Text] [Related]
17. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men. Remes T; Väisänen SB; Mahonen A; Huuskonen J; Kröger H; Jurvelin JS; Penttilä IM; Rauramaa R Bone; 2004 Aug; 35(2):439-47. PubMed ID: 15268895 [TBL] [Abstract][Full Text] [Related]
18. Correlation of Serum CCL3/MIP-1α Levels with Disease Severity in Postmenopausal Osteoporotic Females. Wan H; Qian TY; Hu XJ; Huang CY; Yao WF Balkan Med J; 2018 Jul; 35(4):320-325. PubMed ID: 29666038 [TBL] [Abstract][Full Text] [Related]
19. Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women. Qin YJ; Zhang ZL; Zhang H; Hu WW; Liu YJ; Hu YQ; Li M; Gu JM; He JW Acta Pharmacol Sin; 2008 Dec; 29(12):1493-8. PubMed ID: 19026169 [TBL] [Abstract][Full Text] [Related]